The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study
Article in Cells (February 2024)
The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.
The CDK Pho85 inhibits Whi7 Start repressor to promote cell cycle entry in budding yeast
Article in EMBO Reports (January 2024)
CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma
Article in Journal for ImmunoTherapy of Cancer (November 2023)